● FCE Pharma 2024, Sao Paulo, Brazil

Meet Maithili Life Sciences at the FCE Pharma Event in Brazil : Booth G-140

At Maithili Life Sciences, we are proud to be at the forefront of API (Active Pharmaceutical Ingredient) manufacturing in India, supplying the global pharmaceutical industry with high-quality, cost-effective ingredients. With a commitment to innovation, excellence, and customer satisfaction, we are excited to announce our participation at the upcoming FCE Pharma event in São Paulo, Brazil, from June 4th to 6th, 2024. You can find us at booth No. G-140.

About Us: Maithili Life Sciences is a trusted name in the pharmaceutical industry, known for our dedication to producing APIs and intermediates that meet the highest quality standards. With state-of-the-art manufacturing facilities and a team of experienced professionals, we have established ourselves as a leading supplier to markets around the world.

Our Presence in the Brazilian Market: In recent years, Maithili Life Sciences has made significant strides in expanding our presence in the Brazilian market. Brazil, being one of the largest pharmaceutical markets in Latin America, presents immense opportunities for growth and development. Recognizing this potential, we have strategically invested in strengthening our foothold in the region.

Strengthening Our Presence in the MENA Market

At Maithili Life Sciences, our commitment to excellence is evident in every aspect of our operations. We adhere to stringent quality control measures, ensuring that our APIs and intermediates meet international regulatory standards such as PMDA, cGMP, and WHO-GMP. This dedication to quality ensures our products’ safety, efficacy, and reliability, making us a trusted partner in the Brazilian API market.

Why Choose Maithili Life Sciences?



Quality Assurance:

Quality is at the core of everything we do. Our manufacturing processes adhere to stringent quality standards, ensuring that our products consistently meet regulatory requirements.



Innovative Solutions:

We continuously strive to innovate and develop new products to meet the evolving needs of our customers. Our R&D team is dedicated to exploring new technologies and methodologies to enhance our product offerings.



Cost-Effectiveness:

We understand the importance of cost-effectiveness in today’s competitive market. Through efficient production processes and economies of scale, we are able to offer competitive pricing without compromising on quality.



Customer-Centric Approach:

At Maithili Life Sciences, we prioritize customer satisfaction above all else. We work closely with our clients to understand their specific requirements and tailor our solutions to meet their needs.



Reliability and Timely Delivery:

With our robust supply chain and logistics network, we ensure timely delivery of products to our customers, minimizing lead times and reducing the risk of stockouts.

Our Product Portfolio: Our extensive product portfolio includes a wide range of APIs and intermediates across various therapeutic categories, including but not limited to:

	Key Intermediates	DMF Status	Filing
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Cabergoline Intermediates	Cabergoline Acid
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Minoxidil	-
Modafinil	-
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Ornidazole	-	DMF Available
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Tamsulosin	Tamsulosin Base [106133-20-4]
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Torsemide	-
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Vardenafil	-
Voriconazole	-	DMF Available
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing

	Key Intermediates	DMF Status	Filing
Minoxidil	-
Modafinil	-
Ornidazole	-	DMF Available
Torsemide
Vardenafil
Voriconazole	-	DMF Available
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Cabergoline Intermediates	Cabergoline Acid
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Tamsulosin	Tamsulosin Base [106133-20-4]

	Key Intermediates	DMF Status	Filing
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Cabergoline Intermediates	Cabergoline Acid
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Minoxidil	-
Modafinil	-
Tamsulosin	Tamsulosin Base [106133-20-4]
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Torsemide	-
Vardenafil	-
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Ornidazole	-	DMF Available
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Voriconazole	-	DMF Available
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing

	Key Intermediates	DMF Status	Filing
Benazepril HCl	3-Bromo-2,3,4,5-tetrahydro-2-h-1-benzacepin-2one [86499-96-9], tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate [109010-60-8]
Brivaracetam	(R)-4-Propyldihydrofuran-2(3H)-one [63095-51-2]
Cabergoline Intermediates	Cabergoline Acid
Dapoxetine HCl	3-(Napthalen-1-yloxy)-1-phenylpropan-1-ol [908291-72-5], Dapoxetine Base [119356-77-3]	DMF Available
Darolutamide Intermediates	4-Bromo-2-Chlorobenzonitrile
Etoricoxib	1-(6-Methylpyridin-3-yl)-2-[4-(Methylsulfonyl)Phenyl] Ethanone [Ketosulfone] [221615-75-4], 2-Chloro-1,3-Bis(Dimethylamino) Trimethinium Hexafluoro Phosphate [249561-98-6]
Favipiravir	6-chloro-3-hydroxypyrazine-2-carbonitrile dicyclohexylamine salt [1137606-74-6]	DMF Available
Irbesartan	2-Butyl-1,3-Diazaspiro-[4,4]Non-1-en-4-one hydrochloride (Spiro) [151257-01-1]
Minoxidil	-
Modafinil	-
Ornidazole	-	DMF Available
Solifenacin Succinate	3-Quinuclidinone HCl [1193-65-3], R-(-)-3-Quinuclidinol [25333-42-0], S-1-Phenyl 1,2,3,4 tetrahydro isoquinoline [118864-75-8]	DMF Available
Tadalafil	(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride [171752-68-4]	DMF Available
Tamsulosin	Tamsulosin Base [106133-20-4]
Telmisartan	2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole [152628-02-9]
Ticagrelor	4,6-Dichloro-2-propylthiopyrimidine-5-amine [145783-15-9]	DMF Available
Torsemide	-
Vardenafil	-
Voriconazole	-	DMF Available
Trazodone	1-(3-chlorophenyl)-4-(3-chloropropyl)-Piperazine [52605-52-4], 1,2,4-Triazolo-[4,3-a]pyridine-3(2H)-one [6969-71-7]	DMF Available	ANVISA Filing
Dabigatran Etexilate Mesylate	Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate [212322-56-0]	DMF Available	CEP Filing
Naftidrofuryl Oxalate	1-(tetrahydro-2-furyl)-3-(1-naphthyl) propane-2-carboxylic acid (60% in toluene) [5379-26-4]	DMF Available	CEP Filing
Nebivolol HCl	ISOMER A [793669-26-8], ISOMER B [876514-31-7]	DMF Available	CEP Filing
Sumatriptan Succinate	4-Hydrazino-n-methane benzene methane sulphonamide HCl [88933-16-8], Sumatriptan Base [103628-46-2]	DMF Available	CEP/KDMF/ANVISA Filing
Zaltoprofen	5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid [83237-49-4]		JDMF/KDMF Filing
Azilsartan Medoxomil Potassium Salt	2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid, [147403-03-0], Azilsartan Base	DMF Available	KDMF Filing
Rasagiline Mesylate	1-Aminoindane HCl [70146-15-5], (R)-(-)-1-Aminoindane HCl [10305-73-4]	DMF Available	KDMF/JDMF Filing

Visit Us at FCE Pharma 2024: We cordially invite you to visit our booth at the FCE Pharma event in São Paulo, Brazil, from June 4th to 6th, 2024. Our team will be available to discuss how Maithili Life Sciences can be your trusted partner for API manufacturing solutions in India. Don’t miss this opportunity to learn more about our products and services and explore potential collaborations.